Postural instability in patients with Parkinson's disease: Epidemiology, pathophysiology and management

CNS Drugs

Volumn 27, Issue 2, 2013, Pages 97-112

  Kim, Samuel D ^a,b   Allen, Natalie E ^c   Canning, Colleen G ^c   Fung, Victor S C ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CARBIDOPA; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; METHYLPHENIDATE; NAXAGOLIDE; PERGOLIDE; RASAGILINE; SELEGILINE;

ATTENTION; BALANCE DISORDER; BODY EQUILIBRIUM; BODY POSTURE; BRAIN DEPTH STIMULATION; CLINICAL TRIAL; CONTINUOUS INFUSION; FALLING; GAIT DISORDER; HUMAN; KINESIOTHERAPY; PALLIDOTOMY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOTHERAPY; POSTURAL INSTABILITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; TREADMILL EXERCISE;

EID: 84876909650     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-012-0012-3     Document Type: Review

References (181)

1. Winter DA. Human balance and posture control during standing and walking. Gait Posture. 1995;3:193-214.
2. Bronte-Stewart HM, Minn AY, Rodrigues K, Buckley EL, Nashner LM. Postural instability in idiopathic Parkinson's disease: the role of medication and unilateral pallidotomy. Brain. 2002;125(9):2100-14.
3. Nutt JG, Marsden CD, Thompson PD. Human walking and higher-level gait disorders, particularly in the elderly. Neurology. 1993;43(2):268-79.
4. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368.
5. Klawans HL, Topel JL. Parkinsonism as a falling sickness. JAMA. 1974;230(11):1555.
6. De Boer A, Wijker W, Speelman J, De Haes J. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry. 1996;61(1):70.
7. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, et al. Variable expression of Parkinson's disease. Neurology. 1990;40(10):1529-34.
8. Koller WC, Glatt S, Vetere-Overfield B, Hassanein R. Falls and Parkinson's disease. Clin Neuropharmacol. 1989;12(2):98-105.
9. Adkin AL, Frank JS, Jog MS. Fear of falling and postural control in Parkinson's disease. Mov Disord. 2003;18(5):496-502.
10. Benatru I, Vaugoyeau M, Azulay JP. Postural disorders in Parkinson's disease. Neurophysiol Clin. 2008;38(6):459-65.
11. Hely MA, Morris JG, Rail D, Reid WG, O'Sullivan DJ, Williamson PM, et al. The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years. J Neurol Neurosurg Psychiatry. 1989;52(3):324-8.
12. Hely MA, Morris JG, Traficante R, Reid WG, O'Sullivan DJ, Williamson PM. The Sydney Multicentre Study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry. 1999;67(3):300-7.
13. Hely MA, Morris JGL, Reid WGJ, Trafficante R. Sydney Multicenter Study of Parkinson's disease: non-l-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20(2):190-9.
14. Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL. The Sydney Multicenter Study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23(6):837-44.
15. Song J, Sigward S, Fisher B, Salem GJ. Altered dynamic postural control during step turning in persons with early-stage Parkinson's disease. Parkinsons Dis. (Epub 2012 Jan 29).
16. Mancini M, Horak FB, Zampieri C, Carlson-Kuhta P, Nutt JG, Chiari L. Trunk accelerometry reveals postural instability in untreated Parkinson's disease. Parkinsonism Relat Disord. 2011;17(7):557-62.
17. Deliagina TG, Orlovsky GN, Deliagina TG, Orlovsky GN. Comparative neurobiology of postural control. Curr Opin Neurobiol. 2002;12(6):652-7.
18. Scholz E, Diener H, Noth J, Friedemann H, Dichgans J, Bacher M. Medium and long latency EMG responses in leg muscles: Parkinson's disease. J Neurol Neurosurg Psychiatry. 1987;50(1):66.
19. Dimitrova D, Nutt J, Horak FB. Abnormal force patterns for multidirectional postural responses in patients with Parkinson's disease. Exp Brain Res. 2004;156(2):183-95.
20. Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol. 2001;248(11):950-8.
21. Camicioli R, Majumdar SR. Relationship between mild cognitive impairment and falls in older people with and without Parkinson's disease: 1-year prospective cohort study. Gait Posture. 2010;32(1):87-91.
22. Cole MH, Silburn PA, Wood JM, Worringham CJ, Kerr GK. Falls in Parkinson's disease: kinematic evidence for impaired head and trunk control. Mov Disord. 2010;25(14):2369-78.
23. Mak MKY, Pang MYC. Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical features. J Neurol. 2010;257(9):1543-51.
24. Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA. Predictors of future falls in Parkinson disease. Neurology. 2010;75(2):116-24.
25. Latt MD, Lord SR, Morris JGL, Fung VSC. Clinical and physiological assessments for elucidating falls risk in Parkinsons disease. Mov Disord. 2009;24(9):1280-9.
26. Schwarzel A. Recurrent falls in Parkinson's disease: a narrative review. unpublished honours thesis. The University of Sydney, Sydney; 2011.
27. Pickering RM, Grimbergen YAM, Rigney U, Ashburn A, Mazibrada G, Wood B, et al. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord. 2007;22(13):1892-900.
28. Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G. Burden of illness in Parkinson's disease. Mov Disord. 2005;20(11):1449-54.
29. McCrone P, Allcock LM, Burn DJ. Predicting the cost of Parkinson's disease. Mov Disord. 2007;22(6):804-12.
30. Pressley JC, Louis ED, Tang M-X, Cote L, Cohen PD, Glied S, et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology. 2003;60(1):87-93.
31. Stolze H, Klebe S, Baecker C, Zechlin C, Friege L, Pohle S, et al. Prevalence of gait disorders in hospitalized neurological patients. Mov Disord. 2005;20(1):89-94.
32. Temlett JA, Thompson PD. Reasons for admission to hospital for Parkinson's disease. Intern Med J. 2006;36(8):524-6.
33. Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002;72(6):721-5.
34. Evans JR, Mason SL, Williams-Gray CH, Foltynie T, Brayne C, Robbins TW, et al. The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry. 2011;82(10):1112-8.
35. Hariz G, Forsgren L. Activities of daily living and quality of life in persons with newly diagnosed Parkinson's disease according to subtype of disease, and in comparison to healthy controls. Acta Neurol Scand. 2011;123(1):20-7.
36. Mak MKY, Pang MYC. Balance confidence and functional mobility are independently associated with falls in people with Parkinson's disease. J Neurol. 2009;256(5):742-9.
37. Davey C, Wiles R, Ashburn A, Murphy C. Falling in Parkinson's disease: the impact on informal caregivers. Disabil Rehabil. 2004;26(23):1360-6.
38. Schrag A, Sampaio C, Counsell N, Poewe W. Minimal clinically important change on the unified Parkinson's disease rating scale. Mov Disord. 2006;21(8):1200-7.
39. Franchignoni F, Martignoni E, Ferriero G, Pasetti C. Balance and fear of falling in Parkinson's disease. Parkinsonism Relat Disord. 2005;11(7):427-33.
40. Adkin AL, Frank JS, Carpenter MG, Peysar GW. Fear of falling modifies anticipatory postural control. Exp Brain Res. 2002;143(2):160-70.
41. Thomas AA, Rogers JM, Amick MM, Friedman JH. Falls and the falls efficacy scale in Parkinson's disease. J Neurol. 2010;257(7):1124-8.
42. Dissanayaka NNW, Sellbach A, Matheson S, O'Sullivan JD, Silburn PA, Byrne GJ, et al. Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord. 2010;25(7):838-45.
43. Schaafsma J, Balash Y, Gurevich T, Bartels A, Hausdorff J, Giladi N. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur J Neurol. 2003;10(4):391-8.
44. Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. J Neurol. 2005;252(11):1310-5.
45. Lim I, Van Wegen E, Jones D, Rochester L, Nieuwboer A, Willems A, et al. Identifying fallers with Parkinson's disease using home-based tests: who is at risk? Mov Disord. 2008;23(16):2411-5.
46. Allcock LM, Rowan EN, Steen IN, Wesnes K, Kenny RA, Burn DJ. Impaired attention predicts falling in Parkinson's disease. Parkinsonism Relat Disord. 2009;15(2):110-5.
47. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB. Neurology. 2000;55(11):1621-6.
48. Folstein M, Folstein S, McHugh P. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-98.
49. Rocchi L, Chiari L, Horak F. Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002;73(3):267-74.
50. Schieppati M, Nardone A. Free and supported stance in Parkinson's disease. Brain. 1991;114(3):1227-44.
51. Horak F, Nutt J, Nashner L. Postural inflexibility in parkinsonian subjects. J Neurol Sci. 1992;111(1):46-58.
52. Paul SS, Canning CG, Sherrington C, Fung VSC. Reproducibility of measures of leg muscle power, leg muscle strength, postural sway and mobility in people with Parkinson's disease. Gait Posture. 2012;36(3):639-42.
53. Nardone A, Schieppati M. Balance in Parkinson's disease under static and dynamic conditions. Mov Disord. 2006;21(9):1515-20.
54. Armstrong DM. The supraspinal control of mammalian locomotion. J Physiol (Lond). 1988;405:1-37.
55. Massion J. Postural control systems in developmental perspective. Neurosci Biobehav Rev. 1998;22(4):465-72.
56. Inkster LM, Eng JJ. Postural control during a sit-to-stand task in individuals with mild Parkinson's disease. Exp Brain Res. 2004;154(1):33-8.
57. Bleuse S, Cassim F, Blatt JL, Labyt E, Bourriez JL, Derambure P, et al. Anticipatory postural adjustments associated with arm movement in Parkinson's disease: a biomechanical analysis. J Neurol Neurosurg Psychiatry. 2008;79(8):881-7.
58. Traub M, Rothwell J, Marsden C. Anticipatory postural reflexes in Parkinson's disease and other akinetic-rigid syndromes and in cerebellar ataxia. Brain. 1980;103(2):393.
59. Latash ML, Aruin AS, Neyman I, Nicholas J. Anticipatory postural adjustments during self inflicted and predictable perturbations in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1995;58(3):326-34.
60. Carpenter M, Allum J, Honegger F, Adkin A, Bloem B. Postural abnormalities to multidirectional stance perturbations in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004;75(9):1245-54.
61. Beckley D, Bloem B, Van Dijk J, Roos R, Remler M. Electrophysiological correlates of postural instability in Parkinson's disease. Electroencephalogr Clin Neurophysiol. 1991;81(4):263-8.
62. Chong RKY, Jones CL, Horak FB. Postural set for balance control is normal in Alzheimer's but not in Parkinson's disease. J Gerontol A Biol Sci Med Sci. 1999;54(3):M129-35.
63. Dimitrova D, Horak FB, Nutt JG. Postural muscle responses to multidirectional translations in patients with Parkinson's disease. J Neurophysiol. 2004;91(1):489-501.
64. Horak FB, Dimitrova D, Nutt JG. Direction-specific postural instability in subjects with Parkinson's disease. Exp Neurol. 2005;193(2):504-21.
65. Bloem BR, Beckley DJ, Remler MP, Roos RAC, van Dijk JG. Postural reflexes in Parkinson's disease during 'resist' and 'yield' tasks. J Neurol Sci. 1995;129(2):109-19.
66. Maurer C, Mergner T, Xie J, Faist M, Pollak P, Lucking C. Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease. Brain. 2003;126(5):1146-63.
67. Steiger M, Thompson P, Marsden C. Disordered axial movement in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1996;61(6):645-8.
68. Guehl D, Dehail P, De Seze M, Cuny E, Faux P, Tison F, et al. Evolution of postural stability after subthalamic nucleus stimulation in Parkinson's disease: a combined clinical and posturometric study. Exp Brain Res. 2006;170(2):206-15.
69. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease, vol. 2. Plurham Park: Macmillian Healthcare Information; 1987. p. 153-63.
70. Bloem BR, Beckley DJ, Van Dijk JG, Zwinderman AH, Remler MP, Roos RAC. Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease. Mov Disord. 1996;11(5):509-21.
71. Bloem B, Van Dijk J, Beckley D, Roos R, Remler M, Bruyn G. Altered postural reflexes in Parkinson's disease: a reverse hypothesis. Med Hypotheses. 1992;39(3):243-7.
72. Diener C, Scholz E, Guschlbauer B, Dichagans J. Increased shortening reaction in Parkinson's disease reflects a difficulty in modulating long loop reflexes. Mov Disord. 1987;2(1):31-6.
73. Marsden C. The mysterious motor function of the basal ganglia: the Robert Wartenberg lecture. Neurology. 1982;32(5):514-39.
74. Bloem BR, Beckley DJ, van Vugt JPP, van Dijk JG, Remler MP, Langston JW, et al. Long latency postural reflexes are under supraspinal dopaminergic control. Mov Disord. 1995;10(5):580-8.
75. Horak F, Frank J, Nutt J. Effects of dopamine on postural control in parkinsonian subjects: scaling, set, and tone. J Neurophysiol. 1996;75(6):2380-96.
76. Wright W, Gurfinkel V, Nutt J, Horak F, Cordo P. Axial hypertonicity in Parkinson's disease: direct measurements of trunk and hip torque. Exp Neurol. 2007;208(1):38-46.
77. Vingerhoets FJG, Schulzer M, Calne DB, Snow BJ. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann Neurol. 1997;41(1):58-64.
78. Carpenter MG, Frank JS, Silcher CP, Peysar GW. The influence of postural threat on the control of upright stance. Exp Brain Res. 2001;138(2):210-8.
79. Bloem BR, Hausdorff JM, Visser JE, Giladi N. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord. 2004;19(8):871-84.
80. Burleigh A, Horak F, Nutt J, Frank J. Levodopa reduces muscle tone and lower extremity tremor in Parkinson's disease. Can J Neurol Sci. 1995;22(4):280-5.
81. Dietz V, Zijlstra W, Assaiante C, Trippel M, Berger W. Balance control in Parkinson's disease. Gait Posture. 1993;1(2):77-84.
82. Bloem BR, Beckley DJ, van Dijk JG. Are automatic postural responses in patients with Parkinson's disease abnormal due to their stooped posture? Exp Brain Res. 1999;124(4):481-8.
83. Jacobs JV, Dimitrova DM, Nutt JG, Horak FB. Can stooped posture explain multidirectional postural instability in patients with Parkinson's disease? Exp Brain Res. 2005;166(1):78-88.
84. Bloch F, Houeto JL, Tezenas du Montcel S, Bonneville F, Etchepare F, Welter ML. Parkinson's disease with camptocormia. J Neurol Neurosurg Psychiatry. 2006;77(11):1223-8.
85. Margraf NG, Wrede A, Rohr A, Schulz-Schaeffer WJ, Raethjen J, Eymess A, et al. Camptocormia in idiopathic Parkinson's disease: a focal myopathy of the paravertebral muscles. Mov Disord. 2010;25(5):542-51.
86. Spuler S, Krug H, Klein C, Medialdea IC, Jakob W, Ebersbach G, et al. Myopathy causing camptocormia in idiopathic Parkinson's disease: a multidisciplinary approach. Mov Disord. 2010;25(5):552-9.
87. Azher SN, Jankovic J. Camptocormia: pathogenesis, classification, and response to therapy. Neurology. 2005;65:355-9.
88. van de Warrenburg BPC, Cordivari C, Ryan AM, Phadke R, Holton JL, Bhatia KP, et al. The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy. Mov Disord. 2007;22(16):2325-31.
89. Nantel J, McDonald JC, Bronte-Stewart H. Effect of medication and STN-DBS on postural control in subjects with Parkinson's disease. Parkinsonism Relat Disord. 2012;18(3):285-9.
90. Menant JC, Latt MD, Menz HB, Fung VS, Lord SR. Postural sway approaches center of mass stability limits in Parkinson's disease. Mov Disord. 2011;26(4):637-43.
91. Beckley D, Bloem B, Remler M. Impaired scaling of long latency postural reflexes in patients with Parkinson's disease. Electroencephalogr Clin Neurophysiol. 1993;89(1):22-8.
92. Frank J, Horak F, Nutt J. Centrally initiated postural adjustments in parkinsonian patients on and off levodopa. J Neurophysiol. 2000;84(5):2440-8.
93. Marchese R, Bove M, Abbruzzese G. Effect of cognitive and motor tasks on postural stability in Parkinson's disease: a posturographic study. Mov Disord. 2003;18(6):652-8.
94. Morris M, Iansek R, Smithson F, Huxham F. Postural instability in Parkinson's disease: a comparison with and without a concurrent task. Gait Posture. 2000;12(3):205-16.
95. Vaugoyeau M, Viel S, Amblard B, Azulay J, Assaiante C. Proprioceptive contribution of postural control as assessed from very slow oscillations of the support in healthy humans. Gait Posture. 2008;27(2):294-302.
96. Khudados E, Cody FWJ, O'Boyle DJ. Proprioceptive regulation of voluntary ankle movements, demonstrated using muscle vibration, is impaired by Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;67(4):504-10.
97. Vaugoyeau M, Azulay JP. Role of sensory information in the control of postural orientation in Parkinson's disease. J Neurol Sci. 2010;289(1-2):66-8.
98. Demirci M, Grill S, McShane L, Hallett M. A mismatch between kinesthetic and visual perception in Parkinson's disease. Ann Neurol. 1997;41(6):781-8.
99. Azulay JP, Mesure S, Amblard B, Blin O, Sangla I, Pouget J. Visual control of locomotion in Parkinson's disease. Brain. 1999;122(1):111-20.
100. Pastor M, Day B, Marsden C. Vestibular induced postural responses in Parkinson's disease. Brain. 1993;116(5):1177-90.
101. Vitale C, Marcelli V, Furia T, Santangelo G, Cozzolino A, Longo K, et al. Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion. Mov Disord. 2011;26(8):1458-63.
102. Allen NE, Sherrington C, Paul SS, Canning CG. Balance and falls in Parkinson's disease: a meta-analysis of the effect of exercise and motor training. Mov Disord. 2011;26(9):1605-15.
103. Dibble LE, Addison O, Papa E. The effects of exercise on balance in persons with Parkinson's disease: a systematic review across the disability spectrum. J Neurol Phys Ther. 2009;33(1):14-26.
104. Tomlinson CL, Patel S, Meek C, Clarke CE, Stowe R, Shah L, et al. Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database Syst Rev. 2012;8:CD002817.
105. de Dreu M, van der Wilk A, Poppe E, Kwakkel G, van Wegen E. Rehabilitation, exercise therapy and music in patients with Parkinson's disease: a meta-analysis of the effects of music-based movement therapy on walking ability, balance and quality of life. Parkinsonism Relat Disord. 2012;18:S114-9.
106. Bloem BR, Grimbergen YAM, Cramer M, Valkenburg VV. "Stops walking when talking" does not predict falls in Parkinson's disease. Ann Neurol. 2000;48(2):268.
107. Allen NE, Canning CG, Sherrington C, Lord SR, Latt MD, Close JCT, et al. The effects of an exercise program on fall risk factors in people with Parkinson's disease: a randomized controlled trial. Mov Disord. 2010;25(9):1217-25.
108. Ashburn A, Fazakarley L, Ballinger C, Pickering R, McLellan LD, Fitton C. A randomised controlled trial of a home-based exercise programme to reduce the risk of falling among people with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2007;78(7):678-84.
109. Hirsch MA, Toole T, Maitland CG, Rider RA. The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson's disease. Arch Phys Med Rehabil. 2003;84(8):1109-17.
110. Goodwin VA, Richards SH, Henley W, Ewings P, Taylor AH, Campbell AJ. An exercise intervention to prevent falls in people with Parkinson's disease: a pragmatic randomised controlled trial. J Neurol Neurosurg Psychiatry. 2011;82:1232-8.
111. Toole T, Hirsch MA, Forkink A, Lehman D, Maitland CG. The effects of a balance and strength training program on equilibrium in parkinsonism: a preliminary study. NeuroRehabilitation. 2000;14(3):165-74.
112. Nieuwboer A, Kwakkel G, Rochester L, Jones D, Van Wegen E, Willems A, et al. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry. 2007;78(2):134-40.
113. Kadivar Z, Corcos DM, Foto J, Hondzinski JM. Effect of step training and rhythmic auditory stimulation on functional performance in Parkinson patients. Neurorehabil Neural Repair. 2011;25(7):626-35.
114. Cakit BD, Saracoglu M, Genc H, Erdem HR, Inan L. The effects of incremental speed-dependent treadmill training on postural instability and fear of falling in Parkinson's disease. Clin Rehabil. 2007;21(8):698-705.
115. Toole T, Maitland CG, Warren E, Hubmann MF, Panton L. The effects of loading and unloading treadmill walking on balance, gait, fall risk, and daily function in Parkinsonism. NeuroRehabilitation. 2005;20(4):307-22.
116. Yang Y, Lee Y, Cheng Y, Wang Y. Downhill walking training in individuals with Parkinson's disease. Am J Phys Med Rehabil. 2010;89(9):706-14.
117. Protas EJ, Mitchell K, Williams A, Qureshy H, Caroline K, Lai EC. Gait and step training to reduce falls in Parkinson's disease. NeuroRehabilitation. 2005;20(3):183-90.
118. Marchese R, Diverio M, Zucchi F, Lentino C, Abbruzzese G. The role of sensory cues in the rehabilitation of Parkinsonian patients: a comparison of two physical therapy protocols. Mov Disord. 2000;15(5):879-83.
119. Smania N, Corato E, Tinazzi M, Stanzani C, Fiaschi A, Girardi P, et al. Effect of balance training on postural instability in patients with idiopathic Parkinson's disease. Neurorehabil Neural Repair. 2010;24(9):826-34.
120. Morris M, Iansek R, Kirkwood B. A randomized controlled trial of movement strategies compared with exercise for people with Parkinson's disease. Mov Disord. 2009;24(1):64-71.
121. Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J, et al. Tai Chi and postural stability in patients with Parkinson's disease. New Engl J Med. 2012;366:511-9.
122. Hackney ME, Earhart GM. Tai Chi improves balance and mobility in people with Parkinson's disease. Gait Posture. 2008;28(3):456-60.
123. Hackney ME, Kantorovich S, Levin R, Earhart GM. Effects of tango on functional mobility in Parkinson's disease: a preliminary study. J Neurol Phys Ther. 2007;31(4):173-9.
124. Hackney ME, Earhart GM. Effects of dance on movement control in Parkinson's disease: a comparison of Argentine tango and American ballroom. J Rehabil Med. 2009;41(6):475-81.
125. Hackney ME, Earhart GM. Effects of dance on gait and balance in Parkinson's disease: a comparison of partnered and nonpartnered dance movement. Neurorehabil Neural Repair. 2010;24(4):384-92.
126. PEDro. Physiotherapy Evidence Database rating scale [online]. http://www.pedro.org.au/ [Accessed 2012 Sep 25].
127. Merholz J, Friis R, Kugler J, Twork S, Storch A, Pohl M. Treadmill training for patients with Parkinson's disease (review). Cochrane Database Syst Rev. 2010;20(1):CD007830.
128. Yen C, Lin K, Hu M, Wu R, Lu T, Lin C. Effects of virtual reality-augmented balance training on sensory organization and attentional demand for postural control in people with Parkinson disease: a randomized controlled trial. Phys Ther. 2011;91(6):862-74.
129. Qutubuddin AA, Cifu DX, Armistead-Jehle P, Carne W, McGuirk TE, Baron MS, et al. A comparison of computerized dynamic posturography therapy to standard balance physical therapy in individuals with Parkinson's disease: a pilot study. NeuroRehabilitation. 2007;22(4):261-5.
130. Sherrington C, Whitney J, Lord SR, Herbert R, Cumming R, Close J. Effective exercise for the prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc. 2008;56:2234-43.
131. Allen NE, Sherrington C, Suriyarachchi GD, Paul SS, Song J, Canning CG. Exercise and motor training in people with Parkinson's disease: a systematic review of participant characteristics, intervention delivery, retention rates, adherence, and adverse events in clinical trials. Parkinsons Dis. 2012;2012. doi: 10.1155/2012/854328
132. Smith ST, Sherrington C, Studenski S, Schoene D, Lord SR. A novel dance dance revolution (DDR) system for in-home training of stepping ability: basic parameters of system use by older adults. Br J Sports Med. 2011;45:441-5.
133. Howell S, Tripoliti E, Pring T. Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: a feasibility study. Int J Lang Commun Disord. 2009;44(3):287-300.
134. Wu G, Keyes L, Callas P, Ren X, Bookchin B. Comparison of telecommunication, community, and home-based Tai Chi exercise programs on compliance and effectiveness in elders at risk of falls. Arch Phys Med Rehabil. 2010;91:849-56.
135. Wu GE, Keyes LM. Group tele-exercise for improving balance in elders. Telemed J E Health. 2006;12(5):561-70.
136. Bonato P. Advances in wearable technology and applications in physical medicine and rehabilitation. J Neuroeng Rehabil. 2005;2(2). doi: 10.1186/1743-0003-2-2
137. Vu TC, Nutt JG, Holford NHG. Progression of motor and non-motor features of Parkinson's disease and their response to treatment. Br J Clin Pharmacol. 2012;74(2):267-83.
138. Klawans HL. Individual manifestations of Parkinson's disease after ten or more years of levodopa. Mov Disord. 1986;1(3):187-92.
139. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology. 1987;37(9):1539-42.
140. Burleigh-Jacobs A, Horak FB, Nutt JG, Obeso JA. Step initiation in Parkinson's disease: influence of levodopa and external sensory triggers. Mov Disord. 1997;12(2):206-15.
141. Dick J, Rothwell J, Berardelli A, Thompson P, Gioux M, Benecke R, et al. Associated postural adjustments in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1986;49(12):1378-85.
142. Chung KA, Lobb BM, Nutt JG, Horak FB. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology. 2010;75(14):1263-9.
143. Grimbergen YAM, Langston JW, Roos RAC, Bloem BR. Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus. Exp Rev Neurother. 2009;9(2):279-90.
144. Morgante F, Fasano A. Improvement with duloxetine in primary progressive freezing gait. Neurology. 2010;75(23):2130-2.
145. Auriel E, Hausdorff JM, Herman T, Simon ES, Giladi N. Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease: a pilot study. Clin Neuropharmacol. 2006;29(1):15-7.
146. Pollak L, Dobronevsky Y, Prohorov T, Bahunker S, Rabey J. Low dose methylphenidate improves freezing in advanced Parkinson's disease during off-state. J Neural Transm Suppl. 2007;72:145-8.
147. Devos D, Krystkowiak P, Clement F, Dujardin K, Cottencin O, Waucquier N, et al. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry. 2007;78(5):470-5.
148. Espay A, Dwivedi A, Payne M, Gaines L, Vaughan J, Maddux B, et al. Methylphenidate for gait impairment in Parkinson disease. Neurology. 2011;76(14):1256-62.
149. Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, et al. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol. 2012;11(7):589-96.
150. Giladi N, McDermott M, Fahn S, Przedborski S, Jankovic J, Stern M, et al. Freezing of gait in PD. Neurology. 2001;56(12):1712-21.
151. Shoulson I, Oakes D, Fahn S, Lang A, Langston JW, LeWitt P, et al. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial. Ann Neurol. 2002;51(5):604-12.
152. Rascol O, Brooks D, Melamed E, Oertel W, Poewe W, Stocchi F, et al. Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. Lancet. 2005;365(9463):947-54.
153. Giladi N, Shabtai H, Simon E, Biran S, Tal J, Korczyn A. Construction of freezing of gait questionnaire for patients with parkinsonism. Parkinsonism Relat Disord. 2000;6(3):165-70.
154. Giladi N, Rascol O, Brooks D. Rasagiline treatment can improve freezing of gait in advanced Parkinson's disease: a prospective randomized, double-blind, placebo-and entacapone-controlled study. Neurology. 2004;62(Suppl. 5):A329.
155. Mizuno Y, Kondo T, Takubo H, Yokochi F. A long-term clinical effect of selegiline hydrochloride on Parkinson's disease. No To Shinkei. 1994;46(5):465-71.
156. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, et al. Levodopa and the progression of Parkinson's disease. New Engl J Med. 2004;351(24):2498-508.
157. Bartels AL, Balash Y, Gurevich T, Schaafsma JD, Hausdorff JM, Giladi N. Relationship between freezing of gait (FOG) and other features of Parkinson's:
158. Giladi N. Medical treatment of freezing of gait. Mov Disord. 2008;23(Suppl. 2):S482-8.
159. Parkinson Study Group. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA. 2002;287(13):1653-61.
160. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. New Engl J Med. 2000;342(20):1484-91.
161. Ahlskog JE, Muenter MD, Bailey PA, Stevens PM. Dopamine agonist treatment of fluctuating parkinsonism: D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide). Arch Neurol. 1992;49(5):560-8.
162. Giladi N, Hausdorff JM. The role of mental function in the pathogenesis of freezing of gait in Parkinson's disease. J Neurol Sci. 2006;248(1):173-6.
163. Clarke CE, Worth P, Grosset D, Stewart D. Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease. Parkinsonism Relat Disord. 2009;15(10):728-41.
164. Garcia Ruiz PJ, Sesar Ignacio Å, Ares Pensado B, Castro Garcia A, Alonso Frech F, Ålvarez Lopez M, et al. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study. Mov Disord. 2008;23(8):1130-6.
165. Hughes A, Bishop S, Kleedorfer B, Turjanski N, Fernandez W, Lees A, et al. Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years. Mov Disord. 1993;8(2):165-70.
166. Devos D. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Mov Disord. 2009;24(7):993-1000.
167. Lozano AM, Snyder BJ. Deep brain stimulation for parkinsonian gait disorders. J Neurol. 2008;255:30-1.
168. Lang AE, Obeso JA. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol. 2004;3(5):309-16.
169. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. New Engl J Med. 2003;349(20):1925-34.
170. Bejjani BP, Gervais D, Arnulf I, Papadopoulos S, Demeret S, Bonnet AM, et al. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2000;68(5):595-600.
171. Kumar R, Lozano A, Kim Y, Hutchison W, Sime E, Halket E, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology. 1998;51(3):850-5.
172. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. New Engl J Med. 1998;339(16):1105-11.
173. Faist M, Xie J, Kurz D, Berger W, Maurer C, Pollak P, et al. Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease. Brain. 2001;124(8):1590-600.
174. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease. JAMA. 2009;301(1):63-73.
175. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. New Engl J Med. 1997;337(15):1036-43.
176. Pahwa R, Wilkinson S, Smith D, Lyons K, Miyawaki E, Koller W. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. Neurology. 1997;49(1):249-53.
177. Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport. 2005;16(17):1883-7.
178. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain. 2007;130(6):1596-607.
179. Moro E, Hamani C, Poon YY, Al-Khairallah T, Dostrovsky JO, Hutchison WD, et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain. 2010;133(1):215-24.
180. Pierantozzi M, Palmieri MG, Galati S, Stanzione P, Peppe A, Tropepi D, et al. Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson's disease patients. J Neural Transm. 2008;115(5):731-5.
181. Ferraye M, Debù B, Fraix V, Goetz L, Ardouin C, Yelnik J, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain. 2010;133(1):205-14.